Medicus Pharma Stock Soars 10.44% on SPO Success

Medicus Pharma's stock surged by 10.44% in pre-market trading on May 29, 2025, marking a significant uptick in investor interest.

Medicus Pharma has recently faced volatility in its stock price, with a notable decline of 25.96% during Wednesday's session, bringing the stock price down to $4.56. However, over the past month, the stock has shown resilience, gaining 50.61%. This volatility is likely due to market reactions to the company's recent secondary public offering (SPO) on May 27, 2025, which raised $10,023,750. The SPO involved the issuance of 1.5 million shares at an anticipated price range of $4.00 to $6.00 per share, which could have influenced the stock's recent performance.

Despite the recent decline, Medicus Pharma's stock has seen significant gains over the past month, indicating that investors remain optimistic about the company's prospects. The stock's price target ranges from $12.00 to $27.00, with an average target of $19.67, suggesting that there is potential for further growth. The company is expected to report its FY 2025 earnings on March 30, 2026, which could provide further insights into its financial performance and future outlook.